Intarcia Therapeutics, Inc. Email Format

Biotechnology ResearchMassachusetts, United States51-200 Employees

Intarcia Therapeutics, Inc. is a mid-sized biotechnology research company based in Boston, Massachusetts. The organization aims to redesign how chronic diseases are treated, prevented, and experienced by patients, with the goal of reducing the burden on those living with these conditions. It describes its approach as pursuing novel questions and unconventional ideas through cross-disciplinary teams of scientists and entrepreneurs in a fast-paced setting.

In the biotechnology sector, the firm positions itself as an innovator that seeks measurable improvements in health outcomes, business, and society. In 2023, it completed the sale of assets related to its diabetes drug-eluting implant and the underlying technology to i2o Therapeutics. The development suggests ongoing strategic moves within its asset portfolio while maintaining a broader focus on advances in chronic disease care.

Sign up for free to view info

Company overview Employee directory